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Combination of microfluidics with optical tweezers is used in order to analyze the impact of 
drugs and chemicals on the motility of unicellular parasites 
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Microfluidics-based single cell analysis reveals drug-
dependent motility changes in trypanosomes 
Axel Hochstettera, Eric Stellamannsb,1, Siddharth Deshpandea,2, Sravanti 
Uppalurib,3, Markus Engstlerc, and Thomas Pfohla,b,4  
We	   present	   a	   single	   cell	   viability	   assay,	   based	   on	   chemical	   gradient	  
microfluidics	   in	   combination	  with	  optical	  micromanipulation.	  Here,	  we	  used	  
this	  combination	  to	  in	  situ	  monitor	  the	  effects	  of	  drugs	  and	  chemicals	  on	  the	  
motility	   of	   the	   flagellated	   unicellular	   parasite	   Trypanosoma	   brucei;	  
specifically,	  the	  local	  cell	  velocity	  and	  the	  mean	  squared	  displacement	  (MSD)	  
of	   the	   cell	   trajectories.	  With	   our	  method,	  we	   are	   able	   to	   record	   in	   situ	   cell	  
fixation	   by	   glutaraldehyde,	   and	   to	   quantify	   the	   critical	   concentration	   of	   2-­‐
deoxy-­‐D-­‐glucose	   required	   to	  completely	  paralyze	   trypanosomes.	   In	  addition,	  
we	   detected	   and	   quantified	   the	   impact	   on	   cell	   propulsion	   and	   energy	  
generation	   at	   much	   lower	   2-­‐deoxy-­‐D-­‐glucose	   concentrations.	   Our	  
microfluidics-­‐based	  approach	  advances	   fast	   cell-­‐based	  drug	   testing	   in	   a	  way	  
that	   allows	   us	   to	   distinguish	   cytocidal	   from	   cytostatic	   drug	   effects,	   screen	  
effective	   dosages,	   and	   investigate	   the	   impact	   on	   cell	  motility	   for	   drugs	   and	  
chemicals.	  Using	  suramin,	  we	  could	  reveal	  the	  impact	  of	  the	  widely	  used	  drug	  
on	  trypanosomes:	  Suramin	  lowers	  trypanosome	  motility	  and	  induces	  cell-­‐lysis	  
after	  endocytosis.	  
 
Introduction	  
The discovery of drugs that are effective in the battle against 
rapidly adapting pathogens requires concerted efforts with 
respect to developing improved screening assays and 
understanding of the mode of action of drugs on the target cell. 
To economize these efforts, pharmaceutical research 
increasingly employs cell culture assays that bridge the gap 
between molecular and animal drug testing.1 In many instances, 
analysis of whole cells (cellomics)2 allows for more accurate 
predictions of drug responses than molecular assays because the 
complex molecular interactions and the cellular compartments 
that significantly influence the cell’s reaction to a drug are 
retained.1 Cell culture-based drug discovery commonly 
involves cell chips, high throughput screenings, and cell 
viability assays using fluorescence or luminescent transgenic 
target organisms.1,3–5 Often, these assay systems are unable to 
distinguish between drugs that kill the target cells (cytocidals) 
and drugs that merely inhibit cell growth (cytostatics).6  
In recent years, microfluidics has emerged as a powerful tool 
for the discovery of drugs, as well as for elucidating their 
effects on cells, cell secretions, and signaling pathways.1,7–9 
Moreover, microfluidics has proven useful for exploring 
individual cells in a heterogeneous population.7 The range of 
applications in single cell analysis is increased manifold by 
combining microfluidics with optical tweezers that allow the 
manipulation of cells by miniscule forces without touching.10,11 
Examples include the sorting of motile cells12 and the 
characterization of cell motility13, but also specific placing of 
cells into defined environments.12,14,15  
In single cell assays, the effects of environmental parameters 
are frequently assessed through analysing cell lysates.7,16,17 
However, this type of endpoint analysis excludes further 
investigations of downstream effects. On the other hand, 
physical or biophysical properties of living cells so far are very 
rarely used as readout. The few published examples include 
monitoring bioelectrical impedance18 in response to drug 
treatment or migratory behavior.9 So far, the impacts of drugs 
onto highly motile unicellular pathogens have rarely been 
studied in single cell assays.2 The motility of non-self-
proliferating spermatozoa however has been investigated on the 
single cell level with optical tweezers.19 
Trypanosoma brucei, a unicellular organism belonging to the 
genus of trypanosomes, is one of the most rapidly adapting 
pathogens.20–24 The subspecies T. brucei brucei is endemic in 
sub-Saharan Africa where it causes Nagana disease in 
livestock25, whereas T. brucei rhodesiense and T. brucei 
gambiense are the causative agents of the fatal sleeping 
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sickness in humans (Human African Trypanosomiasis, 
HAT).26–30 
Trypanosomes are extensively studied model flagellates.23,31,32 
The flagellum is structurally different from bacterial flagella 
and more complex than most other eukaryotic flagella.33 
Nonetheless, it is essential for locomotion and viability. 
Moreover, the flagellum is key to evading the immune response 
of the infected mammalian host.32  
Present screening procedures for trypanocidal compounds 
involve either in vitro assays that take several hours5,6,34 or 
in vivo experiments that are based on establishing mutant 
trypanosomes that take weeks35 and therefore, are even more 
time-consuming. 
Here, we introduce a real-time motility analysis system that is 
based on a straightforward microfluidic device in combination 
with time-resolved microscopy and optical tweezers. In the 
device, the concentration of drugs and chemicals is diffusion-
controlled and can be precisely tuned, with simultaneous 
observation of single cells. This setup allows us to physically 
characterize and quantify how drugs and chemicals affect 
trypanosome motility. Specifically, we quantify drug-induced 
reversible paralysis and irreversible chemical fixation of 
trypanosomes in a dose-dependent manner. 
 
 
Materials	  and	  Methods	  
Cell culture and solutions 
Trypanosoma brucei brucei MiTat 1.2 bloodstream form 
trypanosomes were routinely grown in HMI-936 culture 
medium at 37 °C in a 95% air/5% CO2 humidified atmosphere.  
Populations were kept below 106 cells per mL by repetitive 
splitting. After a maximum of 15 splittings, trypanosomes were 
discarded and fresh populations were defrosted. 
For experiments, 2 mL of trypanosomes in culture medium 
were centrifuged at 237 x g and washed once with 2 mL of 
culture medium and once with 2 mL culture medium with 
bovine serum albumin (BSA, 5 mg/mL). The supernatant was 
discarded and the cells were taken up into a 1 mL syringe 
(Braun) in 0.7 mL of culture medium with BSA (5 mg/mL). 
This comprised the cell solution, which was introduced into the 
device. The solution of culture medium and BSA was weekly 
prepared and stored at 37 °C and at 5% CO2 in humid 
atmosphere to ascertain optimal conditions. 
For drug solutions of suramin, the drug was dissolved in 2 mL 
of culture medium and polystyrene beads (1 µμm diameter, 
Polysciences) solution 2 µμL/mL. For drug solutions of GA and 
2DG, 2 mL of culture medium solvent contained additionally 
BSA (5mg/mL) and polystyrene beads (1 µμm diameter, 
Polysciences) solution 2 µμL/mL.  
 
 
Device preparation 
The devices were produced using standard soft lithographic 
methods37 and were made from PDMS (Dow Corning) 
covalently bound to glass cover slides (5 cm diameter, VWR). 
For the inlets and outlets, holes were punched out of the PDMS 
using a punching tool (0.5 mm diameter, Harris) into which 
PTFE-tubings (Fischer-Scientific) were inserted.  
The syringes were equipped with cannulas (0.45 mm diameter, 
Terumo), which were inserted tightly into the PTFE tubings and 
thus connected to computer-controlled neMESYS syringe 
pumps (Cetoni). 
 
Optical tweezers microscope and image analysis 
The optical tweezers setup consisted of a collimated diode laser 
(λ = 808 nm, Schaefter + Kirchhoff GmbH) with Gaussian 
beam-profile coupled into the light path of the microscope to 
generate a single beam gradient-trap. Images were recorded at 
one frame per second on an upright BX61 microscope 
(Olympus), equipped with a 40x water immersion objective 
(NA = 1.15, Olympus) and a Sensicam CCD-camera (PCO). 
The motion of trypanosomes before, during and after exposure 
to drugs was recorded at about 10 frames per second. The 
recorded image stacks were aligned using StackReg38 for Fiji39 
in translation mode. Trajectories of moving trypanosomes 
within stacks were recorded using manual tracking for Fiji39. 
The obtained trajectories were analysed with MATLAB to 
retrieve the mean square displacements (MSDs) and the 
velocity plots of the recorded trajectories. 
 
Fluorescence Imaging 
Fluorescence imaging was conducted with an upright BX61 
microscope (Olympus) and a Sensicam CCD-camera (PCO), 
using a xenon lamp, filter set (𝜆!"# = 535 nm, AHF) and 
rhodamine B as fluorescent dye. Devices were first flushed with 
culture medium and BSA (5 mg/ml) from the cell inlet through 
the device, while the drug inlet was blocked (step I). Then, the 
inlet and the outlet on the cell side were blocked and 
fluorescent drug solution ran through drug side (step III) before 
the device was flushed with rhodamine B solution from the 
drug inlet as shown in figure 1a, step IV. Time-count started 
when the dye-solution pushed out the cell media through the 
device. The fluorescence images (figure S1) were corrected for 
uneven illumination with Gaussian-like distribution. 
For the experiments, only square chambers with a side length of 
62.5 µμm and 75 µμm respectively were used, which explains the 
plateaus in the MSDs around 3900-5625 µμm2. In smaller 
chambers, the trypanosomes would be too confined for proper 
MSDs while bigger chambers would be too big for the field of 
view of the camera. 
 
CFD simulations 
For the computational fluid dynamics (CFD) simulations we 
used the CFD module from the software COMSOL 4.3a. The 
microfluidic device was modeled in 3D using 54,167 finite 
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elements. At first, the stationary laminar flow was calculated, 
whereas in a second step the time dependent material transport 
of the diluted species were calculated by using the beforehand-
obtained stationary flow fields.  
CFD simulations of the distribution of a drug with a diffusion 
coefficient of Ddrug = 5.7.10-10 m2/s (representative for small 
molecules) are shown in supplementary video S1 and S2 and 
figure S1.  
 
 
Results	  
Design and function of the drug testing device 
Our experimental setup for single cell analysis combines 
microfluidics with time-resolved microscopy and optical 
tweezers. The microfluidic structure consists of one main 
channel (width: 40 µm, height: 9 µm), which is linked to 
adjacent square microchambers by connecting channels (width: 
4 µm, length: 12 µm) and ends on both sides in a Y-fork (figure 
1a). 
 
 
Figure	   1:	   Schematic	   representation	   of	   the	   device	   design	   and	   experimental	  
procedure.	   (a):	   The	   symmetric	   device	   consists	   of	   one	   main	   channel	   which	  
supplies	   square	   microchambers	   with	   media,	   cells	   and	   drugs	   from	   the	   inlets.	  
Excessive	   liquid	   is	   exhausted	   via	   the	   outlets.	   Inlets	   and	   outlets	   are	   connected	  
with	   individually	   controllable	   syringe	   pumps.	   In	   combination	   with	   the	   optical	  
trap,	  cells	  are	   loaded	   into	   the	  chambers.	  Due	   to	   the	  syringe	  pump	  control,	   the	  
drug	  can	  be	  preloaded	  on	  the	  drug	  side,	   introduced	   into	  the	  main	  channel	  and	  
removed	   at	   will.	   (b):	   The	   general	   procedure	   consists	   of	   two	   phases.	   In	   the	  
loading	   phase,	   the	   device	   is	   loaded	  with	   cells	   and	  medium	   (I),	   cells	   are	   placed	  
inside	   the	  microchambers	   using	   optical	   tweezers	   (II)	   and	   their	   displacement	   is	  
recorded	  (III).	  During	  the	  drug	  phase,	  drug-­‐solution	  is	  pumped	  through	  the	  main	  
channel	  and	  diffuses	  into	  the	  microchambers	  (IV)	  until	  equilibrium	  is	  reached	  (V).	  
Eventually,	  drug	  free	  cell	  medium	  is	  pumped	  through	  the	  main	  channel	  and	  the	  
drug	  concentration	  inside	  the	  microchambers	  decreases.	  During	  the	  entire	  drug	  
phase,	  cell	  displacement	  is	  recorded.	  
The dimensions of the connecting channels shield the chambers 
from the high flow velocities of the main channel and thus, only 
diffusion-driven material transport into the chambers occurs 
(supporting information S1).37  
All inlets and outlets are attached to controlled microliter 
syringe pumps via Teflon tubing. The syringe pumps can be 
controlled individually, while the device rests on the stage of a 
microscope. 
 
Device operations 
At the beginning of an experiment, the device is flushed with 
culture medium and cells from the cell inlet (step I). When all 
chambers are filled with medium, the flow is stopped. Using 
optical tweezers, individual trypanosomes are trapped, moved 
through the connecting channel into the microchambers and 
then released (step II, see also supplementary video S3).10 Once 
the chosen number of cells occupies the chambers, cell motility 
is recorded in a series of images at about 10 frames per second 
(step III). With the used chamber size (e.g. 75 µm x 75 µm) the 
chosen number reflects the maximum number of cells that can 
be recorded simultaneously without an interference of their 
trajectories (e.g. 2-4). Subsequently, the drug solution is 
pumped from the drug inlet through the main channel (step IV). 
To trace the flow of incoming drug solution, polystyrene 
spheres (1 µm diameter) are added to the drug solution. While 
the drug diffuses into the microchambers, a steady flow in the 
main channel is maintained at vmain ≈ 2 mm/s. Image recording 
is continued until after the drug concentrations inside the 
chambers and the main channel reached (step V) or, if 
applicable, until the drug is completely washed out by pumping 
drug-free culture medium through the device (step VI). 
 
 
Glutaraldehyde motility assay 
We tested the feasibility of single cell analysis in microfluidic 
devices by exposing confined trypanosomes to GA from the 
drug inlet following the procedure described above. The effects 
of GA on trypanosome motility were recorded with a frame rate 
of 10 Hz before and during the inflow of GA. 
Based on sequential images, we determined the centre of mass 
trajectories of the trypanosomes (figure 2) and calculated their 
velocity, 𝑣 𝑡 = ! !!!! !! ! !!! , where r is the position, t is the 
time and Δ𝑡 is the interval between two consecutive images. 
Furthermore, the mean square displacement of the trajectories, 
MSD≡ 𝑟 𝜏 ! = 𝑟 𝑡+ 𝜏 − 𝑟 𝑡 ! , where 𝜏 is the time 
interval, was computed. MSD is a common measure for cellular 
motion10 and can be interpreted as the space which is covered 
over time. In two dimensions, the time dependence of the MSD 
can be described by the following equation:   𝑟 𝜏 ! = 4 ∙𝑀! ∙𝜏!, where α is the scaling exponent and 𝑀! the motility 
coefficient.40 For α > 1, the motion is super-diffusive, for α < 1 
sub-diffusive and for α = 1 diffusive or random walk-like.40,41 
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Figure 2 shows the color-coded time-lapse trajectories of two 
confined trypanosomes over six minutes in culture medium 
(2a,b) and after GA inflow (2c; see also supplementary video 
S4). At the onset of the experiment, when the device is filled 
with culture medium, trypanosomes in microchambers were 
highly motile (figure 2b). Exposure to GA led to a rapid 
fixation of trypanosomes (figure 2c). Velocity analyses 
revealed that their initial velocity of about 3.5 µm/s (green) 
decreased within 1 second to almost zero (figure 2d,e and 
supplementary video S4) after contact with GA (magenta). The 
MSD of trypanosomes moving in a microchamber for 500 s 
prior to fixation (green) and after fixation (magenta) are shown 
in figure 2f. The MSD of motile cells show that trypanosome 
motility is random walk like. At much longer time scales, the 
confinement by the microchamber walls drives the MSD into a 
plateau. 
Conversely, GA-fixed trypanosomes exhibited Brownian rather 
than self-propelled motion. This difference results in a 
downshifting of the MSD of fixed cells by about two orders of 
magnitude. As expected, the fixation process was irreversible, 
since the trypanosomes did not regain motility after the GA 
drug solution in the device had been replaced by culture 
medium (figure 2c). 
 
Figure	   2:	   In	   situ	   cell	   fixation.	   (a)	   Bright-­‐field	  micrograph	   of	   two	   trypanosomes	  
confined	  to	  a	  microchamber.	  (b)	  Overlaid	  color-­‐coded	  time-­‐lapse	  trajectories	  of	  
trypanosomes	  over	  6	  min	   in	  culture	  medium.	   (c)	  Time-­‐lapse	   trajectories	  over	  6	  
min	  after	  the	  addition	  of	  GA.	  (d)	  Velocity	  vs.	  time	  plot	  of	  a	  trypanosome	  before	  
(green),	   during	   (black)	   and	   after	   (magenta)	   fixation	   with	   GA.	   (e)	   Velocity	  
histogram	  of	   several	   trypanosomes	  before	   (green)	  and	  after	   (magenta)	   fixation	  
with	   GA.	   (f)	  MSD	   of	   several	   trypanosomes	   in	   confinement	   before	   (green)	   and	  
after	  GA	  fixation	  (magenta).	  
 
2-Deoxy-D-glucose (2DG) motility assay 
2DG is a glucose analogue that has previously been used to 
investigate trypanosome metabolism and motility.10,20,42,43 For 
our experiments, trypanosomes have been loaded into the 
medium-filled microchambers by optical tweezers and then the 
drug (i.e. 2DG) was preloaded and added at concentrations 
ranging from 4 mM to 1.05 M (figure 1). 2DG diffused into the 
microchambers until it reached the concentration as in the main 
channel (supplementary video S1 and figure S1). Figure 3a 
illustrates how the concentration of 2DG increased gradually 
for 5 minutes and then was reduced again to zero along with the 
concurrent changes of trypanosome swimming velocity 𝑣 𝑡 . 
Trypanosome motility gradually decreased with the inflow of 
2DG. After approximately 4 minutes of 2DG inflow, motility 
suddenly ended. Correspondingly, beyond this critical 
concentration, 𝑣 𝑡  was virtually zero (supplementary video 
S5). However, if the drug was removed by flushing the device 
with culture medium, trypanosomes started to move again at a 
nearly constant 𝑣(𝑡) (supplementary video S6). It was even 
possible to repetitively paralyze and re-activate the same 
trypanosomes. The histograms of 𝑣 𝑡  and MSD for several 
trypanosomes before, during and after paralysis are shown in 
figure 3b and 3c. All MSD exhibit a mean slope of α ≈ 1. In 
comparison to motile cells, the MSD of paralyzed cells were 
downshifted by about two orders of magnitude, thus resembling 
those of trypanosomes fixed by GA. 
 
 
Figure	  3:	  Reversible	  paralyzing	  of	  trypanosomes	  with	  2DG.	   (a)	  Concentration	  of	  
2DG	   in	   the	   chamber	   (top)	   with	   representative	   velocity	   vs.	   time	   plot	   of	   an	  
individual	   trypanosome	   (bottom).	   At	   t	   =	   3	  min,	   2DG	   started	   diffusing	   into	   the	  
microchamber	   and	   the	   cell	   velocity	   decreased	   (green).	   After	   the	   2DG	  
concentration	   reached	  the	  critical	  value	   (here	  around	  4	  min),	   the	   trypanosome	  
was	   completely	   paralyzed	   (magenta).	   In	   response	   to	   the	   inflow	   of	   culture	  
medium,	   2DG	   diffused	   out	   of	   the	   chamber.	   After	   approximately	   6	   min,	   the	  
concentration	  of	  2DG	  was	  below	  the	  critical	  value	  and	  the	  trypanosome	  regained	  
mobility	   (dark	   green).	   (b)	   Histogram	   of	   the	   velocities	   of	   several	   trypanosomes	  
before	   (green)	   and	   above	   the	   critical	   value	   (magenta)	   of	   2DG	  was	   reached,	   as	  
well	  as	  after	  2DG	  concentration	  fell	  below	  the	  critical	  value	  (dark	  green).	  (c)	  MSD	  
of	  trypanosomes	  at	  corresponding	  2DG	  concentrations.	  
From the simulations of the evolution of the 2DG 
concentrations in the microchambers applied to the 
corresponding motility analysis, we calculated the 
concentration of 2DG at which trypanosomes were paralyzed. 
The percentage of trypanosomes found to be paralyzed at 
specific concentrations is plotted in figure 4. Full paralysis in 
trypanosomes occurred at 2DG concentrations of 400 mM and 
higher. At around 515 mM, 50% of the trypanosomes were 
paralyzed, resulting in the paralyzing dosage, PD50 = 515 mM. 
This paralyzing dosage of 515 mM has been confirmed by 
experiments with steady concentrations of 2DG. 
Moreover, our method allowed for the direct observation of the 
evolution of the paralyzing effect on trypanosomes. With 
increasing dosage of 2DG, the trypanosomes moved slower and 
at concentrations close to PD50, the flagellum was still moving, 
whereas the cell body was immobilized (supplementary videos 
S4 & S5). 
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Figure	   4:	   Paralyzing	   dosage	   PD50.	   Percentage	   of	   trypanosomes	   paralyzed	   vs.	  
concentration	  of	  2DG.	  PD50	  denotes	   the	  concentration	  of	  2DG	  at	  which	  50%	  of	  
trypanosomes	  are	  paralyzed.	  
 
Motility factor and low dosage assay  
We examined the effects of 2DG on trypanosome motility at 
concentrations two orders of magnitude lower than the 
measured PD50. For these low concentrations the recorded 
videos showed no obvious impact on trypanosome motility. But 
an increase of 2DG correlated with a downshift of MSD curves 
even at low concentrations (figure 5a).  
For a more quantitative description of the impact of 2DG on the 
motility of trypanosomes, we used a simple hydrodynamic 
model. Whereas paralyzed cells exclusively exhibited 
Brownian motion, the motile cells at different 2DG 
concentrations were characterized by a random walk. Using the 
Stokes-Einstein relation, the motility coefficient of paralyzed 
cells, 𝑀!"#", can be related to the thermal energy, 𝑘!𝑇. The 
friction factor of a paralyzed trypanosome, 𝜉!"#", is linked to its 
diffusion coefficient, D!"#", by 𝑀!"#" = ! ! ! !"#"!! = 𝐷!"#" =!!!!!"#". By analogy, the motility coefficient of the motile, 
randomly walking cells (α = 1),  𝑀!"#$%& ≈𝑀!!! = ! ! ! !"#$%&!! , 
can be described as 𝑀!"#$%& ≅ !!!!!!"#$%&, using a virtual 
temperature, 𝜖𝑇, or an apparent motility energy, 𝜖𝑘!𝑇, where 𝜖 
is a dimensionless factor. Assuming that the friction factors of 
motile and paralyzed cells are almost identical, 𝜉!"#" ≈ 𝜉!"#$%&, 
the motility factor, 𝜖, can be obtained by 𝜖 ≅ !!"#$%&!!"#" =! ! ! !"#$%&! ! ! !"#" . The motility factor 𝜖 𝑐  as a function of the 2DG 
concentration, which is a coarse estimate of the motility energy 
in multiples of 𝑘!𝑇, is presented in figure 5b. A motile 
trypanosome in culture medium utilizes a motility energy that is 
approximately 130 times greater than thermal energy. The 
motility factor 𝜖 𝑐  shows a strong, exponential-like decay with 
increasing concentration of 2DG (0 – 400 mM). However, for 𝜖 𝑐 ≫ 1, the trypanosomes were still motile. At 400 to 
680 mM 2DG, the trypanosomes became paralyzed with a 
PD50 = 515 mM (figure 4). For a motility factor 𝜖 𝑐 = 1 the 
motility energy of a trypanosome equals the thermal energy, 𝑘!𝑇. Thus, propulsion is arrested and only Brownian motion 
occurs.  
 
Figure	  5:	  Analysis	  of	  the	  impact	  of	  2DG	  on	  trypanosome	  propulsion.	  (a)	  MSD	  of	  
trypanosomes	   in	   identical	   chambers	   but	   at	   different	   concentrations	   of	   2DG	   in	  
the	  medium	  (bright	  green:	  drug-­‐free	  culture	  medium,	  dark	  green:	  c2DG	  =	  4	  mM,	  
blue:	   c2DG	   =	   40	  mM,	   black:	   c2DG	   =	   300	  mM,	   magenta:	   fixed	   with	   GA,	   red:	  
paralyzed;	  c2DG	  =	  700	  mM).	  Thin	   lines	  are	  MSD	  of	   individual	  cells,	  bold	   lines	  are	  
averages	  of	   a	  number	  of	   cells	   at	   the	   same	  2DG	  concentration.	   (b)	  The	  motility	  
factor	   𝜖	   plotted	   against	   the	   concentration	   of	   2DG	   in	   the	  medium.	   The	   dashed	  
black	   line	   represents	   a	  motility	   factor	   𝜖	   =	  1,	   which	  means	   that	   the	   propulsion	  
energy	  of	  a	  trypanosome	  equals	  the	  thermal	  energy,	  kBT.	  The	  area	  shaded	  in	  red	  
corresponds	   to	   the	   concentration	   range	   shown	   in	   figure	   4.	   Dashed	   blue	   line	  
serves	  as	  a	  guide	  to	  the	  eye.	  	  
 
Suramin motility and vitality assay 
Suramin was introduced almost a century ago, and despite its 
severe side effects, still is the drug of choice in treating early 
stages of Eastern African sleeping sickness in humans.44–46 The 
route of entry into the trypanosomes as well as the mode of 
action remain enigmatic. Suramin presumably associates with 
different serum proteins in the bloodstream, e.g. low-density 
lipoproteins (LDL).46,47 It has been proposed that suramin’s 
trypanocidal activity arises from its interference with endocytic 
uptake of LDL.47 While it has been indicated that suramin 
might inhibit several enzymes and receptors promiscuously46, a 
more recent study suggests that suranim undergoes receptor-
mediated endocytosis to the lysosome where it escapes to the 
cytoplasm and may inhibit cellular processes48. 
To gain a better understanding on the effects of suramin, we 
tested the response of trypanosomes to the drug in our single 
cell analysis. Similar to 2DG, suramin induced a paralysis of 
confined cells at a critical concentration of PD50 = 123 mM, 
(figure 6a). Moreover, when the drug was flushed out of the 
device by culture medium, paralyzed trypanosomes regained 
motility.  
We quantitatively assessed the impact of suramin on the 
motility of trypanosomes on the basis of MSDs that largely 
exhibit a mean slope of α ≈ 1 (figure 6c). At a concentration of 
3.5 mM suramin, which is significantly below PD50, the 
motility factor 𝜖 was reduced to about one third as compared to 
trypanosomes in a drug-free environment. Between 35 mM and 
80 mM suramin, a steady state with 𝜖 𝑐 ≈ 35 was reached, 
while between 80 and 170 mM, paralysis resulted in 𝜖 𝑐  of 1 
(figure 6d). 
Page 6 of 9Lab on a Chip
ARTICLE	   Journal	  Name	  
6 	  |	  J.	  Name.,	  2012,	  00,	  1-­‐3	   This	  journal	  is	  ©	  The	  Royal	  Society	  of	  Chemistry	  2012	  
Besides the reversible reduction in cell motility, suramin 
exhibited trypanocidal effects. At dosages above 35 mM, 
trypanosomes were found to start rupturing and disintegrating 
after about 6 minutes of exposure to suramin (supplementary 
video S7). The percentage of trypanosomes that disintegrated at 
the end of a time lapse of 14 min increases with the 
concentration of suramin at steady state (figure 6b). 
Interestingly, the suramin-triggered disintegration occurred 
even after suramin removal, indicating that suramin either 
accumulates in trypanosomes or irreversibly alters cell 
regulations.  
 
 
Figure	   6:	   Quantitative	   analysis	   of	   the	   impact	   of	   suramin	   on	   trypanosome	  
propulsion	  and	  disintegration.	  (a)	  Concentration	  dependent	  paralysis	  by	  suramin.	  
PD50	  denotes	   the	   concentration	  of	   suramin	  at	  which	  50%	  of	   trypanosomes	  are	  
paralyzed	  (123	  mM).	  (b)	  Disintegration	  of	  trypanosomes	  in	  response	  to	  different	  
suramin	   concentrations.	   (c)	   MSD	   of	   confined	   trypanosomes	   over	   time	   (bright	  
green:	  drug	   free	  medium,	  dark	  green:	  csuramin	  =	  3.5	  mM,	  blue:	  csuramin	  =	  35	  mM,	  
black:	  c2DG	  =	  100	  mM,	  magenta:	  fixed	  with	  GA,	  red:	  paralyzed;	  csuramin	  =	  210	  mM	  –	  
280	  mM).	  Thin	  lines	  represent	  MSD	  of	  individual	  cells,	  bold	  lines	  are	  averages	  at	  
the	   respective	   suramin	   concentrations.	   (d)	   The	   motility	   factor	   𝜖	   at	   different	  
concentrations	   of	   suramin	   in	   the	   microchamber.	   The	   dashed	   black	   line	  
represents	  𝜖	   =	  1,	  which	   indicates	   that	   the	  propulsion	  energy	  of	   a	   trypanosome	  
equals	  the	  thermal	  energy,	  kBT.	  The	  red	  area	  represents	  the	  concentration	  range	  
shown	  specified	  in	  figure	  6a.	  Dashed	  blue	  line	  serves	  as	  a	  guide	  to	  the	  eye.	  
 
Conclusions 
The quantitative assessment of reversible and irreversible 
paralysis of trypanosomes shows that microfluidics in 
combination with optical micromanipulation is a versatile tool 
for single cell analysis and pharmaceutical testing. Our 
straightforward microfluidics-based method allows not only for 
an in situ analysis of single cells in defined, gradually 
changeable environments but also for a rapid evaluation of the 
impact of drugs and chemicals by analysing cell motility. 
Moreover, this approach eliminates the error of concentration 
inhomogeneity that arises from adding drug solutions drop-wise 
into a cell-laden well that can lead to false results in commonly 
used micro-assays. 
The rapid fixation of trypanosomes with GA represents an 
excellent model for a highly cytocidal drug. We found that 
exposure to GA immediately and irreversibly ended active 
motion. This is most likely a result of cross-linking proteins 
involved in flagellum-dependent parasite motility, e.g. 
dynein49. In contrast, paralysis of trypanosomes was reversible 
when trypanosomes were exposed to respective concentrations 
of 2DG, which is a competitive inhibitor of glycolysis43. Based 
on the precise and rapid control of drug concentrations in the 
confinements, we were able to determine the dosage at which 
50% of the trypanosomes are paralyzed (PD50). Furthermore, 
our data reveal an impact of 2DG on the motility of the cells at 
doses that are significantly lower than PD50.  
We introduced a simple random walk model to derive the 
propulsion energy from cell trajectories. According to this 
model, we noted a reduction of propulsion energy with 
increasing concentration of 2DG. This finding is consistent 
with the decrease in cell motility and with reports of 2DG as 
inhibitor of glycolysis in Trypanosoma brucei bloodstream 
forms.43 It is conceivable that the resulting depletion of ATP 
might cause a decrease in flagellar motor activity and thereby 
reduce cell motility and hence vitality.  
As the cytolysis-free, microfluidics-based single cell analysis 
revealed effects of 2DG at concentrations significantly lower 
than those used in common drug testing systems and had a 
much faster assessment than regularly used assays,4,6 we 
examined the response of trypanosomes to suramin, which is 
still the most commonly used drug in early-stage 
trypanosomiasis. Our data show that suramin and 2DG have 
comparable effects with respect to cell motility, which is likely 
due to suramin blocking endocytosis in trypanosomes. Unlike 
2DG, suramin also caused individual trypanosomes to rupture 
and disintegrate after exposure to concentrations of 35 mM and 
higher. The cytocidal effect of suramin suggests that the two 
drugs affect different cellular mechanisms that ultimately result 
in the inhibition of motility.  
While we characterized our microfluidics-based method with 
established drugs and chemicals that affect Trypanosoma 
brucei brucei, the system lends itself to numerous adaptations, 
like finding and characterizing new drugs against trypanosomes 
or any other pathogenic cell. Further versatility can be easily 
accomplished by integrating additional methodologies, such as 
screening for mutants or fluorescence imaging – live as well as 
after fixation. Moreover, by applying our device to human cells 
and to pathogens simultaneously, effective drug doses could be 
determined in a single experiment. 
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